NCT00007878View on ClinicalTrials.gov

Bortezomib, Fluorouracil, and Leucovorin Calcium in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2000

Primary Completion Date

January 31, 2008

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

bortezomib

Given IV

DRUG

fluorouracil

Given IV

DRUG

leucovorin calcium

Given IV

OTHER

pharmacological study

Correlative studies

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

90033-0804

University of Southern California, Los Angeles

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00007878 - Bortezomib, Fluorouracil, and Leucovorin Calcium in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery | Biotech Hunter | Biotech Hunter